14 May 2007 - Link Technologies Limited, manufacturer of oligonucleotide synthesis reagents, has appointed former President of Avecia Biotechnology Inc, Dr Michael McLean, as Chairman to lead them through an exciting period of change and expansion. The Company is actively seeking business partners to co-develop new products and commercialise and licence new research technologies.
Dr McLean, currently CEO of Oligovax (France), said: "We welcome approaches from interested parties to discuss opportunities. Our chemistry expertise is a perfect match for life science companies working in diverse areas such as molecular diagnostics, microarrays and therapeutics".
 |
www.bionity.com/news/e/64605 |
|
 |
|
|
© Chemie.DE Information Service GmbH http://www.bionity.com/news/e/64605 |
Seydelstr. 28 · 10117 Berlin info@chemie.de · Tel: +49 (0)30 20 45 68 - 0 |